Maximus, Inc. $MMS Shares Bought by Hotchkis & Wiley Capital Management LLC

Key Points

• Hotchkis & Wiley Capital Management LLC increased its stake in Maximus, Inc. by 17.5%, bringing its total ownership to 188,865 shares valued at approximately $12.88 million.
• Maximus reported a quarterly earnings per share of $2.16, significantly surpassing analysts' expectations, with revenue for the quarter reaching $1.35 billion.
• The company announced a quarterly dividend of $0.30, resulting in an annualized yield of 1.4% and will be paid to investors of record on August 15th.

Hotchkis & Wiley Capital Management LLC lifted its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 17.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 188,865 shares of the health services provider's stock after purchasing an additional 28,075 shares during the period. Hotchkis & Wiley Capital Management LLC owned about 0.33% of Maximus worth $12,879,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Mackenzie Financial Corp lifted its position in shares of Maximus by 2.0% during the 4th quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock worth $207,687,000 after purchasing an additional 55,583 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in Maximus by 40.0% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock worth $117,921,000 after acquiring an additional 494,372 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Maximus by 20.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider's stock worth $115,620,000 after acquiring an additional 288,990 shares in the last quarter. Van Berkom & Associates Inc. raised its stake in Maximus by 1.5% during the 1st quarter. Van Berkom & Associates Inc. now owns 1,275,394 shares of the health services provider's stock worth $86,969,000 after acquiring an additional 18,976 shares in the last quarter. Finally, Janus Henderson Group PLC raised its stake in Maximus by 2.0% during the 4th quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider's stock worth $88,546,000 after acquiring an additional 22,711 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently commented on MMS. Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. Based on data from MarketBeat, Maximus has a consensus rating of "Strong Buy" and a consensus target price of $90.00.

Insiders Place Their Bets

In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company's stock.

Maximus Price Performance

MMS traded up $0.10 on Thursday, hitting $87.66. 551,114 shares of the company were exchanged, compared to its average volume of 571,879. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The business's fifty day moving average is $75.55 and its 200 day moving average is $71.38. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.94. The firm has a market capitalization of $4.94 billion, a P/E ratio of 16.14 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company's quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, sell-side analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio (DPR) is presently 22.10%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.